ArticleAnnals of hematology2025

Successful treatment of multi-hit TP53-mutated myelodysplastic syndromes with erythroid predominance using allogeneic stem cell transplantation and ruxolitinib.

Seigi Oshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.